GL1X · GenesisL1 explorer

Research workbench

Selective non-electrophilic thrombin inhibitors

Analyse Selective non-electrophilic thrombin inhibitors in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1C4Y
Type
protein
Length
291 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
THROMBIN:SHORT chain; THROMBIN:LONG chain; Hirugen
EC
3.4.21.5
UniProt
P00734
Ligands
IH3
Pockets
1 · best druggability 0.59

Structure

x-ray diffraction · 3 distinct chains · 15% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
1THROMBIN:SHORT chain (EC 3.4.21.5)protein2726% helix, 0% strandP00734
2THROMBIN:LONG chain (EC 3.4.21.5)protein25413% helix, 33% strandP00734
3Hirugenprotein1030% helix, 0% strand—

Ligands and binding sites

  • IH3 · 2-(2,2-diphenyl-ethyl)-7-methyl-1,3-dioxo-2,3,5,8-tetrahydro-1H-[1,2,4] triazolo[1,2-a]pyridazine-5-carboxylic acid [4-(2-amino-3H-imidazol-4-yl)-cyclohexyl]-amide · ligand · chains 2

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12770.590.7837IH3

Interfaces

2 interfaces between chains.

  • 1–2 · 1115 Ų buried · 25 hydrogen bonds · protein-protein
  • 2–3 · 647 Ų buried · 7 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 1 modified (disulfide, sulfation).

Compared structures

  • 1C4Y · Selective non-electrophilic thrombin inhibitors · the same entry in another collection · chain 2 against 2, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.